Fibromyalgia and resistance to warfarin therapy in a patient with systemic lupus erythematosis and antiphospholipid syndrome

Journal of Clinical Rheumatology

Volumn 2, Issue 5, 1996, Pages 279-282

  Schwartz, Shoshana ^a,b   Siegel, Richard ^b   Getsy, Jay ^a   Callegari, Peter ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HYDROXYCHLOROQUINE; INSULIN; STEROID; TRAZODONE; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROMYALGIA; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; MYALGIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATIC DISEASE; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID DISEASE; THYROID FUNCTION TEST;

EID: 0029957236     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-199610000-00008     Document Type: Article

References (13)

1. Miller FVV, Moore GF, VVeintraub BD, Steinberg AD. Prevalence of thyroid disease and abnormal thyroid function test results in patients with systemic lupus erythematosus. Arthritis Rheum 1987;0:1124-1131.
2. Kausman D, Isenberg DA. Thyroid autoimmunity in systemic lupus erythematosus: the clinical significance of a fluctuating course. Br J Rheumatol 1995;4:361-364.
3. Magaro M, Zoli A, Altomonte L, et al. The association of silent thyroiditis with active sys-ternie lupus erythematosus. Clin Exp Rheumatol 1992;10:67-70.
4. Walters M. The relationship between thyroid function and anticoagulant therapy. Am J Cardiol 1953;11:112-114.
5. Stephens MA, Self TH, Lancaster D, Nash T. Hypothyroidism: effect on warfarin anticoagulation. South Med J 1989;82:1585-1586.
6. van Oosterom AT, Mattie H, Hermens WT, Veitkamp JJ. The influence of the thyroid function on the metabolic rate of prothrombin, factor VII, and factor X in the rat. Thromb Haemost 1976;35:607-619.
7. Self T, Weisburst M, Wooten E, Straughn A, Oliver J. Warfarin-induced hypoprothrombinemia: potentiation by hyperthyroidism. JAMA 1975;231:1165-U66.
8. Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, Rothstein TL, Weigert MG. The role of clonal selection and somatic mutation in autoimmunity. Nature 1987;328:805-811.
9. Shlomchik M, Mascclli M, Shan H, et al. AntiDNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 1990;171:265-292.
10. Shan H, Sholmchik MJ, Marshak-Rothstein A, Pisetsky DS, Lihvin S, Weigert MG. The mechanism of auloantibody production in an autoimmune MRL/lpr mouse. J Immunol 1994; 153:5104-5120.
11. Green LM, LaBue M, Lazarus JP, Colburn KK. Characterization of autoimmune thyroiditis in MRL-lpr/lpr mice. Lupus 1995;4:187-196.
12. Morita S, Arima T, Matsuda M. Prevalence of nonthyroid specific autoantibodies in autoimmune thyroid diseases. J Clin Endocrinol Metab 1995;SO:1203-1206.
13. Miller FVV, Moore GF, Weintraub BD, Steinberg AD. Prevalence of thyroid disease and abnormal thyroid function test results in patients with systemic lupus erythematosus. Arthritis Rheum 1987;30:1124-1131.